NGS Workflow Overview The NGS workflow is a multi-step process that creates some challenges for the diagnostic testing laboratory. The chemical processes generate many daughter samples that must be traced back to the original parent specimen. Laboratories need effective naming conventions and a robust LIMS that can maintain chain of custody across the workflow and […]
Acquisition extends CliniSys capabilities into new and complementary market sectors serving environmental, water quality testing, public health, toxicology, and agriculture.
Acquisition extends CliniSys capabilities into new and complementary market sectors serving environmental, water quality testing, public health, toxicology, and agriculture.
As we reflect on 2021, the ApolloLIMS team has noticed some interesting developments in the diagnostics space. The combination of the COVID-19 pandemic along with some other general developments within the biotech sector overall have combined to impact the diagnostic space for the better. The last year has been an exciting time to partner with […]
Save Trees! (and money, errors, and headaches) Going paperless. That’s been a call of many different computer systems for year, especially LIMS. And yes, there is a real, tangible benefit based on the cost savings involved in less paper. It manifests itself quickly and is completely sustainable. It is fiscally responsible. Plus, it immediately checks […]
Where Does All The Laboratory Waste Go? Paul Canevaro from U.S. Ecology (https://www.usecology.com/) will discuss the mechanisms and procedures for the handling of laboratory waste. This talk will speak to the waste classification, handling and final disposal, whether through landfill or incinerations. About US Ecology: US Ecology services a wide range of companies nationwide who […]
In our Part 1 of this blog series, we discussed the changes we are anticipating in the centralized testing model for COVID-19. There are some changes in store for the COVID-19 diagnostics market driven by the increase in the number of recent authorizations by the US Food and Drug Administration (FDA) for point-of-care (and point of need) […]
CliniSys Group has created a single brand for the UK and Europe, with a new website, color palette and logo. What does it all mean for us, our customers and business partners? Michael Simpson, Group Chief Executive Officer explains. Hello and welcome to the new CliniSys | MIPS website! A single name brand for CliniSys […]
In February, the Biden administration released its National Strategy for the COVID-19 Response and Pandemic Preparedness, which outlines seven goals that address a domestic response and global response to the current COVID-19 pandemic and prepare for future health-related threats. Foundationally, the plan’s goals revolve around establishing a science-based approach to countermeasures against the COVID-19 pandemic that […]
In its simplest form at CliniSys, it is about ‘joining the dots’ and bringing the organisation together as one powerful brand and voice. Marketing planning is already underway and starting in the first quarter of 2021 there will be a series of initiatives to support the CliniSys Group’s marketing and corporate goals.
